SCHEMBL23949506

SCHEMBL23949506

Cc1nc(N2CCOCC2)sc1C(O)c1cc(C#N)ccc1Cl

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 2/20 0.41
PPARG P37231 2/20 0.41
PIK3CD O00329 1/20 0.39
PIK3CA P42336 1/20 0.39
PIK3CB P42338 1/20 0.39
ALOX5 P09917 1/20 0.38
PTGS2 P35354 1/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
MAPT P10636 2/20 0.38
RAB9A P51151 2/20 0.38
KMT2A Q03164 2/20 0.37
DUSP3 P51452 1/20 0.37
PTPN5 P54829 1/20 0.37
PTPN11 Q06124 1/20 0.37
CRHR1 P34998 1/20 0.37
CRHR2 Q13324 1/20 0.37
LMNA P02545 1/20 0.37
PRKDC P78527 1/20 0.37
KCNH2 Q12809 1/20 0.37
KDM4E B2RXH2 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23949662 0.76 PIK3CD (0.52) ALOX15PPARGPIK3CDPIK3CAPIK3CB
SCHEMBL16264541 0.67 SMN1; SMN2 (0.59) ALOX15ALOX5PTGS2SMN1; SMN2MAPT
SCHEMBL12219870 0.67 PIK3CD (0.55) ALOX15PIK3CDPIK3CAPIK3CBSMN1; SMN2
SCHEMBL28989187 0.67 PIK3CD (0.50) PPARGPIK3CDPIK3CAPIK3CBALOX5
SCHEMBL30353361 0.67 PIK3CD (0.50) PPARGPIK3CDPIK3CAPIK3CBALOX5
SCHEMBL427668 0.65 MAPK1 (0.64) PPARGSMN1; SMN2MAPTKMT2ALMNA
SCHEMBL23949226 0.63 PPARG (0.55) PPARGPIK3CAMAPTRAB9AKMT2A
SCHEMBL6120600 0.61 PIK3CD (0.51) ALOX15PIK3CDPIK3CAPIK3CBSMN1; SMN2
SCHEMBL25396850 0.61 PDE4D (0.49) PIK3CAALOX5PTGS2KMT2APRKDC
SCHEMBL4850658 0.61 PIK3CD (0.61) ALOX15PIK3CDPIK3CAPIK3CBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167073-A1 ARYL OR HETEROARYL DERIVATIVE TEIJIN PHARMA LIMITED (JP) 2023-06-01 US disclosed
CN-115996910-A Aryl or heteroaryl derivatives 帝人制药株式会社 2023-04-21 CN disclosed
EP-4137481-A1 ARYL OR HETEROARYL DERIVATIVE Teijin Pharma Limited (JP) 2023-02-22 EP disclosed
WO-2021210650-A1 ARYL OR HETEROARYL DERIVATIVE 帝人ファーマ株式会社 2021-10-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167073-A1 ARYL OR HETEROARYL DERIVATIVE ARRB1, NR3C2, TRPC6 ALOX15 3002/4885PPARG 2184/4885PIK3CD 3472/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.